ASBP
Aspire Biopharma
ASBP
ASBP
59 hedge funds and large institutions have $268M invested in Aspire Biopharma in 2023 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 11 increasing their positions, 11 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.4% less ownership
Funds ownership: 89.36% → 88.96% (-0.4%)
Holders
59
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$8.59M | |
| 2 | +$7.41M | |
| 3 | +$6.17M | |
| 4 |
MC
Meteora Capital
Boca Raton,
Florida
|
+$4.06M |
| 5 |
AC
Aristeia Capital
Greenwich,
Connecticut
|
+$3.89M |
Top Sellers
| 1 | -$14.4M | |
| 2 | -$6.55M | |
| 3 | -$6.19M | |
| 4 |
Verition Fund Management
Greenwich,
Connecticut
|
-$3.06M |
| 5 |
SC
Sculptor Capital
New York
|
-$2.64M |